CARL ZEISS MEDITEC AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.1 EUR | -1.59% |
|
+0.51% | +0.26% |
| Apr. 24 | CARL ZEISS MEDITEC AG : Gets a Buy rating from UBS | ZD |
| Apr. 23 | CARL ZEISS MEDITEC AG : Receives a Sell rating from JP Morgan | ZD |
| Sales 2024 * | 2.27B 2.42B | Sales 2025 * | 2.55B 2.72B | Capitalization | 8.86B 9.45B |
|---|---|---|---|---|---|
| Net income 2024 * | 258M 275M | Net income 2025 * | 326M 347M | EV / Sales 2024 * | 4.17 x |
| Net Debt 2024 * | 584M 622M | Net Debt 2025 * | 402M 428M | EV / Sales 2025 * | 3.63 x |
| P/E ratio 2024 * |
33.9
x | P/E ratio 2025 * |
26.8
x | Employees | 4,823 |
| Yield 2024 * |
1.07% | Yield 2025 * |
1.24% | Free-Float | 40.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Carl Zeiss Meditec AG
More recommendations
More press releases
More news
| 1 day | -1.59% | ||
| 1 week | +0.51% | ||
| Current month | -14.42% | ||
| 1 month | -14.42% | ||
| 3 months | -1.44% | ||
| 6 months | +31.57% | ||
| Current year | +0.26% |
1 week
98.10
103.00
1 month
94.80116.60
Current year
91.54123.75
1 year
72.60123.75
3 years
72.60202.00
5 years
67.70202.00
10 years
19.83202.00
| Managers | Title | Age | Since |
|---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
| Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-12-31 |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.71% | 202 M€ | -.--% | ||
| 0.52% | 2 M€ | +13.56% | - | |
| 0.49% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 99.1 | -1.59% | 112,598 |
| 24-04-29 | 100.7 | +0.40% | 117,623 |
| 24-04-26 | 100.3 | +1.31% | 89,815 |
| 24-04-25 | 99 | -1.39% | 82,762 |
| 24-04-24 | 100.4 | -2.14% | 178,345 |
Delayed Quote Xetra, April 30, 2024 at 11:35 am EDT
More quotes
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Calendar
2024-05-07
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
99.1
EUR
Average target price
108.7
EUR
Spread / Average Target
+9.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.26% | 9.48B | |
| +7.15% | 217B | |
| +6.60% | 183B | |
| +9.86% | 131B | |
| +24.32% | 106B | |
| -0.95% | 62.16B | |
| +11.04% | 51.02B | |
| +4.81% | 50.89B | |
| -1.43% | 40.16B | |
| +24.40% | 31.44B |
- Stock Market
- Equities
- AFX Stock
